Status:
COMPLETED
A Study of BIIB022 in Combination With Paclitaxel and Carboplatin in Subjects With Non-Small Cell Lung Cancer
Lead Sponsor:
Biogen
Conditions:
Non-Small Cell Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
The purpose of this study is to determine whether BIIB022, Paclitaxel and Carboplatin are effective in the treatment of Treatment-Naive, Stage IIIB/IV Non-Small Cell Lung Cancer.
Eligibility Criteria
Inclusion
- Age \>/= 18 years old
- Treatment-naive Stage IIIB/IV Non-Small Cell Lung Cancer
- ECOG Performance Status 0 or 1
Exclusion
- History of another primary cancer within 3 years
- Any prior or concurrent investigational or standard therapy for treatment of NSCLC
- Prior anti-IGF-1R therapy
- Unstable diabetes
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT00970580
Start Date
October 1 2009
End Date
September 1 2011
Last Update
September 16 2013
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Resesarch Site
Los Angeles, California, United States
2
Resesarch Site
San Diego, California, United States
3
Resesarch Site
Denver, Colorado, United States